ML18193B050
| ML18193B050 | |
| Person / Time | |
|---|---|
| Site: | 03034138 |
| Issue date: | 06/25/2018 |
| From: | Robert Gallaghar NRC Region 1 |
| To: | Williamson Memorial Hosp |
| References | |
| 608465 | |
| Download: ML18193B050 (3) | |
Text
NRC FORM 374 U.S. NUCLEAR REGULATORY COMMISSION MATERIALS LICENSE PAGE 1 OF 3 PAGES Amendment No. 19 Pursuant to the Atomic Energy Act of 1954, as amended, the Energy Reorganization Act of 1974 (Public Law 93-438), and Title 10, Code of Federal Regulations, Chapter I, Parts 30, 31, 32, 33, 34, 35, 36, 37, 39, 40, 70 and 71, and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued authorizing the licensee to receive, acquire, possess, and transfer byproduct, source, and special nuclear material designated below; to use such material for the purpose(s) and at the place(s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part(s). This license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954, as amended, and is subject to all applicable rules, regulations, and orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below. Licensee 1. Williamson Memorial Hospital 2. 859 Alderson Street Williamson, WV 25661-3215
- 6. Byproduct, source, 7. and/or special nuclear material A. Any byproduct material A. permitted by 10 CFR 35.100 B. Any byproduct material B. permitted by 10 CFR 35.200 In accordance with email dated April 13, 201a. 4. Expiration Date: October 31, 2021 t------------~
- 5. Docket No.: 030-34138 Reference No.: 3. License number: 47-25358-01 is amended in its entirety to read as follows: Chemical and/or physical form 8. Maximum amount that licensee 9. Authorized use may possess at any one time under this license Any A. As Needed A. For use in uptake, dilution and excretion studies permitted by 10 CFR 35.100. Any B. As Needed B. For use in imaging and localization studies permitted by 10 CFR 35.200. ~. CONDITIONS
- 10. Licensed material may be used or stored only at the licensee's facilities located at 859 Alderson Street, Williamson, West Virginia.
- 11. The Radiation Safety Officer for this license is Travis Painter, M.S. 12. Licensed material shall only be used by, or under the supervision of: t NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 2 OF 3 PAGES License Number Docket or Reference Number MATERIALS LICENSE 47-25358-01 030-34138 SUPPLEMENTARY SHEET Amendment No. 19 A. Individuals permitted to work as authorized users in accordance with 10 CFR 35.13 and 10 CFR 35.14. B. The following individuals are authorized users forthe material and medical uses as indicated:
Authorized User(M.D.,0.0.,etc.)
Material and Use Mark J. Akers, M.D. 10 CFR 35.100, 10 CFR 35.200 Paul D. Akers, M.D. 10 CFR 35.100,10 CFR 35.200 Jeremy F. Cuda, M.D. 10 CFR 35.100, 10 CFR 35.200 Hans G. Dransfeld, M.D. 10 CFR 35.100, 1 tf~*'SS.200 Joseph W. Dransfeld, M.D. 10 CFR 35.100,10 CFR 35.200 Joshua Dale Gibson, M.D. . 10 CFR 35.100, 10 CFR 35.200 Eric L. Leonard, M.D. . 10 CFR 35.100, 10 CFR 35.200 Matthew E. Maxwell, M.D. 10 CFR 35.100, 1 O CFR 35.200 Grant D. Petty, M.D. 10 eFR 35.100, 10 CFR 35.200 Torin P. Walters, M.D. 10 CFR 35:100, 10 CFR 35.200 . James K. Watson, M.D. 10 CFR 35.-100,1cf c'F-R 35.200 13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the minimum limit specified in 10 CFR 30.35(d) for establishing decommissioning financial assurance.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 3 OF 3 PAGES MATERIALS LICENSE SUPPLEMENTARY SHEET License Number 47-25358-01 Amendment No. 19 Docket or Reference Number 030-34138
- 14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements, representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to those procedures that are required to be submitted in accqrctaricewitfdtua regulations.
Additionally, this license condition does not limit the licensee's ability to make changes to the radiation protectton program as proviped for in 10 CFR 35.26. The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the licensee's application and correspondence are more restrictive than the regulations.
A. Application dated June 13, 2011 [ML111671999]
B. Letter dated October 14, 2011 [Ml.:.112930065]
C. Letter dated December 6, 2013 [MU3358A151]
D. Letter dated February 5, 2014 [ML"14049A295]
E. Letters dated February 28, 2018 and March 8, 2018 [ML 18074A203]
F. Letter dated April 13, 2018 [ML 18110A181].
G. Letter dated May 25, 2018 [ML 18162A221].
FOR THE U.S. NUCLEAR REGULATORY COMMISSION Date: June 25, 2018 L.--.